Health

Switchback Medical Signs Lease for 18,000 Square Foot Facility in Costa Ricas Coyol Free Trade Zone

BROOKLYN PARK, MN, April 13, 2026 (GLOBE NEWSWIRE) -- Switchback Medical, a medical device contract development and manufacturing organization (CDMO),…

GlobeNews Wire

Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting

Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability scores, and eliminated the need for chronic immunotherapies…

GlobeNews Wire

AIM ImmunoTech Announces Publication of Journal Article On the Positive Effect of Ampligen and Interferon-Alpha on Tumor Growth

OCALA, Fla., Sept. 22, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that…

GlobeNews Wire
- Advertisement -
Latest Health News

MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results

TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF)…

GlobeNews Wire

Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 07, 2026 19:07 ET  | Source: Cue Biopharma, Inc. BOSTON, May…

GlobeNews Wire

SteelPower Male Enhancement Ingredient Research Gains Attention Amongst Men for Powerful Performance Support

Aurora, CO, May 06, 2026 (GLOBE NEWSWIRE) -- These statements have not…

GlobeNews Wire

Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated…

GlobeNews Wire

InnoCare Announces Approval of Clinical Trial of Novel CDH7 targeted ADC ICP-B208 in China

BEIJING, May 06, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE:…

GlobeNews Wire

Novo Nordisk’s adjusted operating profit reached DKK 32,858 million in Q1 2026

Bagsværd, Denmark, 6 May 2026 - Financial report for the period 1…

GlobeNews Wire